Table 1: Patients and tumor characteristics.
Surgical group |
One-step |
Two-step A (without TTT) |
Two-step B (with TTT) |
Three-step |
P# |
Siewert type (II / III) Gender (Female / Male) Age (years) Histology (AD / SCC / special types) Depth of tumor invasion* (T1 / T2 / T3 / T4) Lymph node metastasis* (N0 / N1 / N2 / N3) TNM stage* (I / II / III / IV) Presence of NAC |
(n = 16) 5 / 11 4 / 12 71±10
15 / 0 / 1
5 / 6 / 2 / 4
6 / 5 / 3 / 2
5 / 3 / 7 / 1 5 |
(n = 8) 3 / 5 1 / 7 71±6
7 / 1 / 0
4 / 0 / 3 / 1
4 / 1 / 2 / 1
4 / 0 / 4 / 0 1 |
(n = 13) 12 / 1 3 / 10 65±14
9 / 3 / 1
5 / 4 / 3 / 1
7 / 5 / 1 / 0
7 / 3 / 3 / 0 3 |
(n = 9) 8 / 1 3 / 6 71±9
5 / 3 / 1
6 / 1 / 1 / 1
5 / 2 / 0 / 2
5 / 1 / 2 / 1 1 |
0.0011 0.7947 0.7793
0.3126
0.3858
0.7850
0.6437 0.6468 |
Data given as number of patients or mean ± SD. TTT: technique for transthoracic transection of the esophagus during the abdominal phase. AD: adenocarcinoma. SCC: squamous cell carcinoma. NAC: neoadjuvant chemotherapy.
*Pathological staging.
#ANOVA or χ2 test.